IX Biopharma    Last:0.355    +0.01

iX Biopharma

Short start work must hold

 

Bb busy at medteck

 

this stock game over Liao later will fall liao

 

Hiat

SmallSmall      ( Date: 05-May-2020 09:29) Posted: For those Interested to know more about the company' s Waferix patent which has vast applications for many drugs Waferix Sublingual Technology The WaferiXTM  technology consists of a small wafer prepared by proprietary formulation using the freeze-drying process. The wafer is intended to be placed under the tongue, which subsequently dissolves within one minute, releasing the active compounds for rapid absorption in a time sensitive manner. The wafer administration is reported to be tolerable with no after-taste, leaving behind no residue or grittiness under the tongue hence preventing the urge to swallow. The WaferiXTM  technology provides a simple drug carrier matrix with millions of tiny amorphous holes to house (encapsulate) the active drug molecules in a cost-effective manner of delivering drugs which otherwise cannot be administered orally due to their poor oral absorption and/or extensive loss to the first pass hepatic metabolism. The only way to administer these drugs is by intravenous (&ldquo IV&rdquo ) administration but sometimes the IV route may be impractical (e.g. in traumatic conditions like severe burns). There is also the issue of phobia of injections especially in children and some elderly in which case, the sublingual oral delivery of a pharmaceutical drug is more desirable. For health care workers, it will help prevent needle-stick injuries in compliance to occupational, health and safety practices. The rapid and superior absorption characteristics provide higher bioavailability and a potential to lower the administered dose and reduce the concurrent side effects. These benefits allow for the application of WaferiXTM  in conditions where instantaneous therapeutic effect is desired, like acute or breakthrough pain as well as male erectile dysfunction. WaferiXTM  is a multiple platform drug carrier technology that was used to develop the world' s first sublingual ketamine oral wafer, WafermineTM  . We have also used WaferiXTM  in our pharmaceutical products, to deliver active compounds like sildenafil citrate (WafesilTM  ) and buprenorphine (BnoXTM  ). In our nutraceuticals range, we have also applied WaferiXTM  to WaferestTM  to deliver melatonin, and to LumeniXTM  to deliver glutathione. Our technology is easily adaptable to a vast number of other FDA approved drugs that require a faster delivery or reduction in the loss of drugs due to hepatic and gastrointestinal metabolism.     Patent Our products are patented in all key markets, including Australia, China, India, Japan, South Korea, Hong Kong SAR, Macau SAR, European Union (Germany, France, United Kingdom, Italy, Spain, Netherlands, Turkey, Switzerland, Sweden, Poland, Belgium, Austria, Norway, Denmark, Ireland and Finland), Canada, South Africa, New Zealand, Singapore, Malaysia, Vietnam and Indonesia, and have been allowed in USA and Israel. The claims of the patents cover a fast-dissolving oral dosage form for the release of a biologically active material in the oral cavity. Additionally, the particular dosage form may contain and deliver a wide range of biologically active materials and is not limited to a specific biologically active material. Methods for the production of the fast dissolving oral dosage form are also provided. Our patents strategy includes the use of the Patent Cooperation Treaty system with a view to obtain broad protection for our patent portfolio, which covers the WaferiX® technology, our products as well as potential new formulations. We aim to secure intellectual property protection for our invention and products in all relevant jurisdictions, as and when necessary. In most countries, the term awarded for a granted patent is 20 years from the date of application. https://www.youtube.com/embed/xv8Bc5-GGp0

 

Oh ok. Hahaha 😆

HengOngHuat88      ( Date: 06-May-2020 09:03) Posted: ask u buy more IX Bio share, later huat liao go Disney enjoy hahaha HendriJB      ( Date: 06-May-2020 08:05) Posted: What Xi Biopharma got to do with Disney? ENTITY SEES STRONG DEMAND FROM CHINA ON BOTH E-COMMERCE STORES  The initial stock of Entity?s sublingual glutathione wafers, LumeniX, is fully sold on Tmall Global and JD Worldwide while RestoriX, its nicotinamide supplement, is fully sold on JD Worldwide  Entity commenced sale of its next-generation nutraceuticals on Tmall Global and JD Worldwide in early April Singapore, 4 May 2020 ? Entity has seen exceptional demand for its LumeniX and RestoriX nutraceutical products less than three weeks into the opening of Entity flagship stores on JD Worldwide and Tmall Global. Initial stock of LumeniX has sold out on both of Entity?s Tmall Global and JD Worldwide stores, and RestoriX is sold out on its JD Worldwide store, ahead of initial forecasts provided by its marketing agencies in China. Entity?s leading beauty supplement, LumeniX, is a novel sublingual wafer containing glutathione, the master of all antioxidants, formulated using iX Biopharma?s WaferiX drug delivery technology. LumeniX is a dual-purpose supplement designed to promote skin fairness, while helping the body to build a stronger immunity against viral infections. Glutathione is normally effective for skin brightening when given intravenously in clinics by trained healthcare workers. Through the use of WaferiX, a delivery technology clinically proven to increase absorption and bioavailability of active ingredients, an effective glutathione product is now available to the mass consumer market. RestoriX is a nicotinamide supplement designed to boost NAD (nicotinamide adenine dinucleotide) levels in the body. NAD is a molecule that Harvard Medical School geneticists have studied in recent years for its ability to switch off ?ageing? genes. RestoriX aims to counter the process of ageing and increase health span, while boosting energy levels and vitality. Ms Eva Tan, Director of Corporate and Commercial Strategy of iX Biopharma said: ?We are very encouraged to have received such strong support from the Chinese consumers during our store launches. We observed that the Chinese consumers are purchasing LumeniX not only because it is a novel beauty product, but they are also responding to LumeniX?s ability to boost the body?s immune system, which can help to protect against viral infections. Overall we are delighted by the quick take-up of LumeniX and RestoriX, which reflects the strong demand by Chinese consumers for innovative, functional nutraceuticals that characterise the Entity line of products.? Both stores will be restocked shortly to meet the growing demand. At the rate of the initial response, plus the growth projected by the agencies, Entity will hit its wafer production capacity very soon. The iX Biopharma group has invested in new equipment which will significantly

 

ask u buy more IX Bio share, later huat liao go Disney enjoy hahaha

HendriJB      ( Date: 06-May-2020 08:05) Posted: What Xi Biopharma got to do with Disney? ENTITY SEES STRONG DEMAND FROM CHINA ON BOTH E-COMMERCE STORES  The initial stock of Entity?s sublingual glutathione wafers, LumeniX, is fully sold on Tmall Global and JD Worldwide while RestoriX, its nicotinamide supplement, is fully sold on JD Worldwide  Entity commenced sale of its next-generation nutraceuticals on Tmall Global and JD Worldwide in early April Singapore, 4 May 2020 ? Entity has seen exceptional demand for its LumeniX and RestoriX nutraceutical products less than three weeks into the opening of Entity flagship stores on JD Worldwide and Tmall Global. Initial stock of LumeniX has sold out on both of Entity?s Tmall Global and JD Worldwide stores, and RestoriX is sold out on its JD Worldwide store, ahead of initial forecasts provided by its marketing agencies in China. Entity?s leading beauty supplement, LumeniX, is a novel sublingual wafer containing glutathione, the master of all antioxidants, formulated using iX Biopharma?s WaferiX drug delivery technology. LumeniX is a dual-purpose supplement designed to promote skin fairness, while helping the body to build a stronger immunity against viral infections. Glutathione is normally effective for skin brightening when given intravenously in clinics by trained healthcare workers. Through the use of WaferiX, a delivery technology clinically proven to increase absorption and bioavailability of active ingredients, an effective glutathione product is now available to the mass consumer market. RestoriX is a nicotinamide supplement designed to boost NAD (nicotinamide adenine dinucleotide) levels in the body. NAD is a molecule that Harvard Medical School geneticists have studied in recent years for its ability to switch off ?ageing? genes. RestoriX aims to counter the process of ageing and increase health span, while boosting energy levels and vitality. Ms Eva Tan, Director of Corporate and Commercial Strategy of iX Biopharma said: ?We are very encouraged to have received such strong support from the Chinese consumers during our store launches. We observed that the Chinese consumers are purchasing LumeniX not only because it is a novel beauty product, but they are also responding to LumeniX?s ability to boost the body?s immune system, which can help to protect against viral infections. Overall we are delighted by the quick take-up of LumeniX and RestoriX, which reflects the strong demand by Chinese consumers for innovative, functional nutraceuticals that characterise the Entity line of products.? Both stores will be restocked shortly to meet the growing demand. At the rate of the initial response, plus the growth projected by the agencies, Entity will hit its wafer production capacity very soon. The iX Biopharma group has invested in new equipment which will significantly Superkilat      ( Date: 06-May-2020 07:11) Posted: https://www.cnbc.com/2020/05/05/disney-dis-q2-2020-earnings.html

 

What Xi Biopharma got to do with Disney?

ENTITY SEES STRONG DEMAND FROM CHINA ON BOTH E-COMMERCE STORES

 The initial stock of Entity?s sublingual glutathione wafers, LumeniX, is fully sold on Tmall Global and JD Worldwide while RestoriX, its nicotinamide supplement, is fully sold on JD Worldwide

 Entity commenced sale of its next-generation nutraceuticals on Tmall Global and JD Worldwide in early April
Singapore, 4 May 2020 ? Entity has seen exceptional demand for its LumeniX and RestoriX nutraceutical products less than three weeks into the opening of Entity flagship stores on JD Worldwide and Tmall Global. Initial stock of LumeniX has sold out on both of Entity?s Tmall Global and JD Worldwide stores, and RestoriX is sold out on its JD Worldwide store, ahead of initial forecasts provided by its marketing agencies in China.
Entity?s leading beauty supplement, LumeniX, is a novel sublingual wafer containing glutathione, the master of all antioxidants, formulated using iX Biopharma?s WaferiX drug delivery technology. LumeniX is a dual-purpose supplement designed to promote skin fairness, while helping the body to build a stronger immunity against viral infections. Glutathione is normally effective for skin brightening when given intravenously in clinics by trained healthcare workers. Through the use of WaferiX, a delivery technology clinically proven to increase absorption and bioavailability of active ingredients, an effective glutathione product is now available to the mass consumer market.

RestoriX is a nicotinamide supplement designed to boost NAD (nicotinamide adenine dinucleotide) levels in the body. NAD is a molecule that Harvard Medical School geneticists have studied in recent years for its ability to switch off ?ageing? genes. RestoriX aims to counter the process of ageing and increase health span, while boosting energy levels and vitality.
Ms Eva Tan, Director of Corporate and Commercial Strategy of iX Biopharma said: ?We are very encouraged to have received such strong support from the Chinese consumers during our store launches. We observed that the Chinese consumers are purchasing LumeniX not only because it is a novel beauty product, but they are also responding to LumeniX?s ability to boost the body?s immune system, which can help to protect against viral infections. Overall we are delighted by the quick take-up of LumeniX and RestoriX, which reflects the strong demand by Chinese consumers for innovative, functional nutraceuticals that characterise the Entity line of products.?
Both stores will be restocked shortly to meet the growing demand. At the rate of the initial response, plus the growth projected by the agencies, Entity will hit its wafer production capacity very soon. The iX Biopharma group has invested in new equipment which will significantly

Superkilat      ( Date: 06-May-2020 07:11) Posted: https://www.cnbc.com/2020/05/05/disney-dis-q2-2020-earnings.html

 

https://www.cnbc.com/2020/05/05/disney-dis-q2-2020-earnings.html

 

This stock not strong. Dont want to play with it liao.... 
Play AEM more exciting. LOL

kennethkzy      ( Date: 05-May-2020 17:02) Posted: hahaha same as yeterday  lovetoshare      ( Date: 05-May-2020 17:01) Posted: touch 280 now really can ge

 

good close. Higher than yesterday close.

 

hahaha same as yeterday 

lovetoshare      ( Date: 05-May-2020 17:01) Posted: touch 280 now really can get 7ocean      ( Date: 05-May-2020 13:58) Posted: Don' t dream too much.. she will sail to 0.4

 

touch 280 now

really can get

7ocean      ( Date: 05-May-2020 13:58) Posted: Don' t dream too much.. she will sail to 0.4 kennethkzy      ( Date: 05-May-2020 13:49) Posted: waiting for 280

 

IX Bio the name not nice. .fengshui not good. wait drop back to 0.14 .....All laugh.

 

Stock is like that. Unpredictable. You expect it to be like yesterday and it will just turn out differently.

 

Same story yesterday sell down

 

Never push up so sell down after 3 pm like yesterday ???

chanbs      ( Date: 05-May-2020 13:27) Posted: Stacking game ... this one

 

Don' t dream too much.. she will sail to 0.4

kennethkzy      ( Date: 05-May-2020 13:49) Posted: waiting for 280

 

waiting for 280

 

again 3 cannot break

 

All sleeping mode